Treatment of Infantile Hemangiomas With Beta-Blockers

A Review

Sonal Shah, MD; Ilona J. Frieden, MD


Skin Therapy Letter. 2013;18(6) 

In This Article


Propranolol and other β-blockers have revolutionized the treatment of IH and led to new insights in the pathophysiology and management of this disease. While propranolol is undeniably effective, more studies are needed to elucidate its mechanism of action and confirm optimal dosing, duration of therapy, and safey, as well as determine risks for rebound growth.